Harmony Biosciences Holdings, Inc.
HRMY
$31.43
$0.491.58%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.88% | -12.70% | -7.91% | 7.34% | 297.66% |
| Total Depreciation and Amortization | 0.02% | -0.02% | 0.00% | 0.00% | -1.39% |
| Total Amortization of Deferred Charges | -1.23% | -1.81% | -1.78% | -3.43% | -0.57% |
| Total Other Non-Cash Items | 8.42% | 144.28% | 97.27% | -36.99% | -83.31% |
| Change in Net Operating Assets | 123.27% | 152.20% | -263.52% | 35.13% | 180.64% |
| Cash from Operations | 37.07% | 133.40% | -55.02% | 7.18% | 65.43% |
| Capital Expenditure | -1,675.00% | 96.88% | 75.05% | -17,000.00% | 99.53% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 75.91% | -886.55% | 137.31% | -992.25% | 103.54% |
| Cash from Investing | 75.55% | -929.34% | 132.86% | -1,064.70% | 101.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -64.04% | -55.44% | 45.38% | 25.71% | 349.39% |
| Repurchase of Common Stock | 100.00% | 21.02% | 41.29% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -11.54% | -663.07% | 87.16% | -133.28% | 65.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 76.94% | 58.49% | -45.15% | -6.33% | 546.74% |